Your browser doesn't support javascript.
loading
Omalizumab in an 8-year-old boy with diabetes mellitus and refractory chronic spontaneous urticaria
Jesenak, M; Ciljakova, M; Janickova, M; Banovcin, P.
Affiliation
  • Jesenak, M; Comenius University in Bratislava. Jessenius Faculty of Medicine in Martin. Martin. Slovakia
  • Ciljakova, M; Comenius University in Bratislava. Jessenius Faculty of Medicine in Martin. Martin. Slovakia
  • Janickova, M; University Teaching Hospital. Department of Stomatology and Maxillofacial Surgery. Martin. Slovakia
  • Banovcin, P; Comenius University in Bratislava. Jessenius Faculty of Medicine in Martin. Martin. Slovakia
J. investig. allergol. clin. immunol ; 29(2): 144-146, 2019. tab
Article in En | IBECS | ID: ibc-184061
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
No disponible
Subject(s)
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Urticaria / Thyroiditis, Autoimmune / Diabetes Mellitus, Type 1 / Omalizumab Limits: Child / Humans / Male Language: En Journal: J. investig. allergol. clin. immunol Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Urticaria / Thyroiditis, Autoimmune / Diabetes Mellitus, Type 1 / Omalizumab Limits: Child / Humans / Male Language: En Journal: J. investig. allergol. clin. immunol Year: 2019 Document type: Article